Dai Hongwei, a professor at the Central University of Finance and Economics: We must give full play to the advantages of central cities in scientific and technological innovation. Dai Hongwei, a professor and doctoral supervisor at the Central University of Finance and Economics, believes that it is necessary to actively cultivate new growth poles for innovation to drive regional economic growth. We must give full play to the radiation-driven role of central cities, especially in the context of innovation-driven development. We must pay attention to giving full play to the advantages of central cities in scientific and technological innovation, driving the development of surrounding areas, accelerating the development of new quality productivity, and at the same time give full play to the important role of urban agglomerations in promoting collaborative innovation and group development. (SSE)The self-built valuation model of bank wealth managers has met with "standardization": some institutions have re-adopted the strategy of excess return of the bank's tier-2 capital bonds with the valuation system of China Securities and China Securities, and recently, the regulatory authorities issued a document to the bank wealth management subsidiary, demanding that the self-built valuation model should not be used to smooth the net value fluctuation, and the valuation standards provided by third parties such as China Securities and China Securities should be adopted, and self-inspection and rectification should be carried out. The purpose of this move is to prevent the bank's wealth management subsidiaries from adjusting product income through self-built models, and to carry out "fund pool" business in disguise to ensure market fairness. At present, a number of bank wealth management subsidiaries have received this document, and have begun to adjust the net value calculation methods of day-opening and closed wealth management products, and re-adopt third-party valuation for investment products such as bank tier 2 capital bonds. A person from a bank financing subsidiary told reporters that he heard that the financial supervision department held a small-scale meeting last week, asking the bank financing subsidiary to respect the new asset management rules and not to violate accounting standards. In addition, the relevant departments also require the financial subsidiaries of banks that have used the self-built valuation model to carry out rectification, and the financial subsidiaries that have been notified shall submit corresponding rectification plans and measures reports within one month. In the view of the above-mentioned bank wealth managers, it is not excluded that some bank wealth management subsidiaries have lowered the allocation ratio of bank tier-2 capital bonds due to the influence of regulatory policies, because when the self-built valuation model is "standardized", the strategy of over-allocating bank tier-2 capital bonds to obtain excess returns becomes increasingly difficult when the net product value fluctuates relatively smoothly. (per meridian)Market News: It is reported that Iraq's strategic wheat reserve is enough to meet the consumption for more than six months.
Huangshan Capsule: It is planned to distribute a cash dividend of 0.27 yuan for every 10 shares. Huangshan Capsule announced that the company held the board of directors and the board of supervisors on December 13, 2024, and reviewed and approved the profit distribution plan for the first three quarters of 2024. According to the plan, the company plans to distribute a cash dividend of RMB27 to all shareholders for every 10 shares based on the existing total share capital of 299 million shares, with a total cash dividend of RMB8,075,700. This profit distribution will not send bonus shares, and capital reserve will not be converted into share capital.Domestic futures opened mixed at night, with Shanghai Gold down 0.57%, Shanghai Silver down more than 1%, Shanghai Zinc up 0.68%, thread down 0.5%, coking coal down 0.6%, glass down 1.22% and crude oil up nearly 1%.Guangzhou Institute: Make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. With the rapid development of polysilicon industry, the relationship between supply and demand changes rapidly and the price fluctuates greatly due to various factors such as industrial policy, production cycle and technological progress. Due to the lack of objective and continuous price signals, the polysilicon industry has concentrated capacity investment and construction, which is prone to problems such as staged supply and demand mismatch, which is not conducive to the healthy and stable development of the industry. In this context, photovoltaic industry chain enterprises have increasingly strong demands for listed polysilicon futures, pricing with futures tools and managing risks. At the same time, the listed polysilicon futures will help to export the international pricing benchmark, form the "China" price of polysilicon international trade reflecting China's industrial volume, and gradually enhance China's influence in polysilicon international trade pricing. The insiders believe that at present, the industrial silicon varieties in Guangzhou have been running smoothly for nearly two years, and the listing of polysilicon varieties will further improve the variety layout of the crystalline silicon industrial chain for futures services, and provide more accurate futures tools for polysilicon and its downstream photovoltaic industrial chain, which is conducive to further consolidating the global competitive advantage of China's photovoltaic and other industries. The relevant person in charge of the Guangzhou Stock Exchange said that in the next step, under the guidance of the China Securities Regulatory Commission, the Guangzhou Stock Exchange will make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. (Guangzhou Institute)
Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months. Peng Qinghua met with Babacov, Vice Chairman of Russian State Duma, and Peng Qinghua, Vice Chairman of the National People's Congress Standing Committee (NPCSC), met with Babacov, Vice Chairman of Russian State Duma, in Beijing on the 13th. The two sides indicated that they will jointly implement the important consensus reached by the two heads of state, make good use of the platform of the joint working group of the Sino-Russian Parliamentary Cooperation Committee, deepen exchanges and cooperation between legislative bodies, and promote the further development of China-Russia comprehensive strategic partnership of cooperation in the new era. (Xinhua News Agency)